首页|干眼症的药物治疗策略及研究进展

干眼症的药物治疗策略及研究进展

扫码查看
干眼症(DED)是一种复杂的多因素疾病,表现出不同的症状,这些症状可影响视觉功能,导致日常生活活动受限,工作效率降低,从而严重影响生活质量。本综述对目前临床上DED的治疗药物以及市场上正在开发的DED治疗策略进行总结,旨在对临床研究提供参考。
Drug treatment strategy and research progress of dry eye disease
Dry eye disease(DED)is a complex and multifactorial disease with different symptoms.These symptoms can affect visual function,resulting in limited activities of daily living and reduced work efficiency,thus seriously affecting the quality of life.This review provides a summary of the current clinical therapeutic drugs for DED and the developing therapeutic strategies for DED in the market,aiming to provide a reference for clinical research.

Dry eye diseaseTreatment optionsRrtificial tearsNonsteroidal anti-inflammatory drugsTivanisiranIL-1R antagonistEBI-005

秦红倩、许卉

展开 >

烟台大学,山东烟台 264000

干眼症 治疗策略 人工泪液 非甾体抗炎药 Tivanisiran IL-1R拮抗剂 EBI-005

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(2)
  • 21